Clinical Trial Update: A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 study evaluated the safety and preliminary efficacy of combining surufatinib with gemcitabine in pediatric, adolescent, and young adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Lymphoma
• Non-rhabdomyosarcoma Soft Tissue Sarcoma
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Surufatinib (Surufatinib)

Snippet

Sponsor: Hutchmed | Conditions: Solid Tumor, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-16